CTBP1 and cancer: It has been proved that β3-ARs are over-expressed in the TME and that they are involved in angiogenesis, cancer progression and tumor stromal cell reactivity [15,16]; therefore, the targeting of β-ARs has been suggested as a possible therapeutic approach for cancer treatment.